Linde Books $425 Million Restructuring Charge, Moves Lincare Out Of Americas Segment
CFO Matt White says Linde can't assure a strategic option exists for the home-care unit, which now sits in Global Other.
Linde cannot promise a buyer or other strategic option will emerge for Lincare, its U.S. home-care business, CFO Matt White told analysts on the industrial-gas maker's third-quarter earnings call Thursday. The company booked a $425 million restructuring charge in the quarter and moved Lincare into its Global Other segment.
A $425 million charge and a segment move
CEO Sanjiv Lamba said roughly half of the charge covers severance, particularly in lower-growth regions. The balance goes primarily to portfolio and asset actions, mostly in U.S. home care.
Lamba said he realigned Lincare to report directly to White. Three months ago, he said, Linde's results "were not up to the expectation of our owners," and the message was received loud and clear.
Answering a Citi analyst, White said the segment move was driven by accounting and by a change in executive oversight. Linde will keep evaluating options, he said, "but we can't assure there will be a strategic option to be had." The job, he said, is to run Lincare better while running it safely and compliantly.
He compared it with Linde's earlier GIST business, which moved to the other segment and ended up sold: "We'll see what happens in this case."
What Lincare costs the earnings line
White said Lincare is costing about 2% of EPS growth year to date, and offsetting that would support a return to double-digit EPS growth. Linde is not embedding any meaningful Lincare profit change in fourth-quarter guidance.
Lamba said that as the portfolio shrinks, healthcare sales will lag the market, though he expects better quality and profitability in what remains. Healthcare grew 2% in the quarter, or mid-single digits excluding Lincare.
Taking Lincare out of the Americas segment removed almost $2.3 billion of annualized sales, White said. The smaller denominator makes Americas pricing recovery look more pronounced.
Quarter and outlook
Linde makes and sells industrial gases, delivering them by pipeline, tanker and cylinder to customers in healthcare, chemicals, electronics and other industries. Third-quarter sales of $9.4 billion, operating profit of $2.8 billion and EPS of $4.59 were all quarterly records, Lamba said. Sales rose 9%, and operating margin of 29.4% fell 30 basis points from a year earlier.
For the fourth quarter, Linde guides to EPS of $4.40 to $4.50, or 5% to 7% growth. The full-year range is $17.82 to $17.92.
White said severance paybacks run one to two years, closer to two for this charge, with full run-rate benefits in the second half of next year. Linde will give 2027 guidance in February.
Lamba said the $8 billion sale-of-gas project backlog will provide future growth, and the February guidance will show how much of Lincare's drag has eased.
Sources
- Linde lifts FY earnings outlook as Q3 beats street views (LIN:NASDAQ) | Seeking Alpha — seekingalpha.com
- EQS-News: Linde Reports Third-Quarter 2026 Results (Earnings Release Tables Attached) – Company Announcement - FT.com — Financial Times
- Linde Reports Third-Quarter 2026 Results – Company Announcement - FT.com — Financial Times
- Linde Gears Up to Report Q3 Earnings: What's in Store for the Stock? — Yahoo Finance
- Earnings Report Could Be A Key Test For Linde Stock (LIN) — Yahoo Finance